Isoforms of 11beta-hydroxysteroid dehydrogenase in human granulosa-lutein cells. 1997

A E Michael, and M Evagelatou, and D P Norgate, and R J Clarke, and J W Antoniw, and B A Stedman, and A Brennan, and R Welsby, and I Bujalska, and P M Stewart, and B A Cooke
Department of Biochemistry and Molecular Biology, Royal Free Hospital School of Medicine, University of London, UK.

To date, two isoforms of 11beta-hydroxysteroid dehydrogenase (11betaHSD) have been characterized: a low affinity, NADP+-dependent isoform (11betaHSD1) and a high affinity, NAD+-dependent isoform which metabolizes dexamethasone and is inhibited by cortisone (11betaHSD2). Having previously reported a relationship between ovarian 11betaHSD activities and conception in women undergoing in vitro fertilization (IVF-ET), the objective of the present study was to identify which isoforms of 11betaHSD metabolize glucocorticoids in cultures of human granulosa-lutein cells. In both intact cells and cell homogenates, two distinct 11betaHSD activities were identified with differing affinities for cortisol (Km = 490 nM and 2.6 microM). Even at low concentrations, cortisol oxidation was preferentially supported by NADP+ and was independent of NAD+. Although inhibited by the hemisuccinate ester of glycyrrhetinic acid, carbenoxolone, the predominant 11betaHSD activity in intact cells was resistant to end-product inhibition. Intact cells were also able to reduce [3H]cortisone (Km = 190 nM) but did not metabolize [3H]dexamethasone. 11BetaHSD1 mRNA was expressed in 23 of 28 cell cultures whereas 11betaHSD2 mRNA was not expressed in any of the 22 independent cultures studied by reverse transcriptase-polymerase chain reaction (RT-PCR). We conclude that human granulosa-lutein cells express both type 11betaHSD and a novel isoform of this enzyme. While the low affinity 11beta-dehydrogenase and 11-ketosteroid reductase activities exhibit properties consistent with 11betaHSD1, the high affinity 11beta-dehydrogenase differs from 11betaHSD2 in that it is NADP+-dependent, does not metabolize dexamethasone and is resistant to end-product inhibition.

UI MeSH Term Description Entries
D007527 Isoenzymes Structurally related forms of an enzyme. Each isoenzyme has the same mechanism and classification, but differs in its chemical, physical, or immunological characteristics. Alloenzyme,Allozyme,Isoenzyme,Isozyme,Isozymes,Alloenzymes,Allozymes
D002478 Cells, Cultured Cells propagated in vitro in special media conducive to their growth. Cultured cells are used to study developmental, morphologic, metabolic, physiologic, and genetic processes, among others. Cultured Cells,Cell, Cultured,Cultured Cell
D005260 Female Females
D005938 Glucocorticoids A group of CORTICOSTEROIDS that affect carbohydrate metabolism (GLUCONEOGENESIS, liver glycogen deposition, elevation of BLOOD SUGAR), inhibit ADRENOCORTICOTROPIC HORMONE secretion, and possess pronounced anti-inflammatory activity. They also play a role in fat and protein metabolism, maintenance of arterial blood pressure, alteration of the connective tissue response to injury, reduction in the number of circulating lymphocytes, and functioning of the central nervous system. Glucocorticoid,Glucocorticoid Effect,Glucorticoid Effects,Effect, Glucocorticoid,Effects, Glucorticoid
D006107 Granulosa Cells Supporting cells for the developing female gamete in the OVARY. They are derived from the coelomic epithelial cells of the gonadal ridge. Granulosa cells form a single layer around the OOCYTE in the primordial ovarian follicle and advance to form a multilayered cumulus oophorus surrounding the OVUM in the Graafian follicle. The major functions of granulosa cells include the production of steroids and LH receptors (RECEPTORS, LH). Cell, Granulosa,Cells, Granulosa,Granulosa Cell
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D006913 Hydroxysteroid Dehydrogenases Enzymes of the oxidoreductase class that catalyze the dehydrogenation of hydroxysteroids. (From Enzyme Nomenclature, 1992) EC 1.1.-. Hydroxysteroid Dehydrogenase,Dehydrogenase, Hydroxysteroid,Dehydrogenases, Hydroxysteroid
D012333 RNA, Messenger RNA sequences that serve as templates for protein synthesis. Bacterial mRNAs are generally primary transcripts in that they do not require post-transcriptional processing. Eukaryotic mRNA is synthesized in the nucleus and must be exported to the cytoplasm for translation. Most eukaryotic mRNAs have a sequence of polyadenylic acid at the 3' end, referred to as the poly(A) tail. The function of this tail is not known for certain, but it may play a role in the export of mature mRNA from the nucleus as well as in helping stabilize some mRNA molecules by retarding their degradation in the cytoplasm. Messenger RNA,Messenger RNA, Polyadenylated,Poly(A) Tail,Poly(A)+ RNA,Poly(A)+ mRNA,RNA, Messenger, Polyadenylated,RNA, Polyadenylated,mRNA,mRNA, Non-Polyadenylated,mRNA, Polyadenylated,Non-Polyadenylated mRNA,Poly(A) RNA,Polyadenylated mRNA,Non Polyadenylated mRNA,Polyadenylated Messenger RNA,Polyadenylated RNA,RNA, Polyadenylated Messenger,mRNA, Non Polyadenylated
D016133 Polymerase Chain Reaction In vitro method for producing large amounts of specific DNA or RNA fragments of defined length and sequence from small amounts of short oligonucleotide flanking sequences (primers). The essential steps include thermal denaturation of the double-stranded target molecules, annealing of the primers to their complementary sequences, and extension of the annealed primers by enzymatic synthesis with DNA polymerase. The reaction is efficient, specific, and extremely sensitive. Uses for the reaction include disease diagnosis, detection of difficult-to-isolate pathogens, mutation analysis, genetic testing, DNA sequencing, and analyzing evolutionary relationships. Anchored PCR,Inverse PCR,Nested PCR,PCR,Anchored Polymerase Chain Reaction,Inverse Polymerase Chain Reaction,Nested Polymerase Chain Reaction,PCR, Anchored,PCR, Inverse,PCR, Nested,Polymerase Chain Reactions,Reaction, Polymerase Chain,Reactions, Polymerase Chain
D042842 11-beta-Hydroxysteroid Dehydrogenases Hydroxysteroid dehydrogenases that catalyzes the reversible conversion of CORTISOL to the inactive metabolite CORTISONE. Enzymes in this class can utilize either NAD or NADP as cofactors. 11 beta-Hydroxysteroid Dehydrogenase,11-Hydroxysteroid Dehydrogenase,11B-Hydroxysteroid Dehydrogenase,11beta-Hydroxysteroid Dehydrogenase,Corticosteroid 11-Oxidoreductase,Corticosteroid 11-Reductase,Cortisone 11-Oxoreductase,11 Hydroxysteroid Dehydrogenase,11 beta Hydroxysteroid Dehydrogenase,11 beta Hydroxysteroid Dehydrogenases,11-Oxidoreductase, Corticosteroid,11-Oxoreductase, Cortisone,11-Reductase, Corticosteroid,11B Hydroxysteroid Dehydrogenase,11beta Hydroxysteroid Dehydrogenase,Corticosteroid 11 Oxidoreductase,Corticosteroid 11 Reductase,Cortisone 11 Oxoreductase,Dehydrogenase, 11 beta-Hydroxysteroid,Dehydrogenase, 11-Hydroxysteroid,Dehydrogenase, 11B-Hydroxysteroid,Dehydrogenase, 11beta-Hydroxysteroid,Dehydrogenases, 11-beta-Hydroxysteroid,beta-Hydroxysteroid Dehydrogenase, 11

Related Publications

A E Michael, and M Evagelatou, and D P Norgate, and R J Clarke, and J W Antoniw, and B A Stedman, and A Brennan, and R Welsby, and I Bujalska, and P M Stewart, and B A Cooke
July 2003, The Journal of endocrinology,
A E Michael, and M Evagelatou, and D P Norgate, and R J Clarke, and J W Antoniw, and B A Stedman, and A Brennan, and R Welsby, and I Bujalska, and P M Stewart, and B A Cooke
October 1997, Molecular and cellular endocrinology,
A E Michael, and M Evagelatou, and D P Norgate, and R J Clarke, and J W Antoniw, and B A Stedman, and A Brennan, and R Welsby, and I Bujalska, and P M Stewart, and B A Cooke
December 2006, Endocrinology,
A E Michael, and M Evagelatou, and D P Norgate, and R J Clarke, and J W Antoniw, and B A Stedman, and A Brennan, and R Welsby, and I Bujalska, and P M Stewart, and B A Cooke
October 2008, Steroids,
A E Michael, and M Evagelatou, and D P Norgate, and R J Clarke, and J W Antoniw, and B A Stedman, and A Brennan, and R Welsby, and I Bujalska, and P M Stewart, and B A Cooke
April 2000, Kidney international,
A E Michael, and M Evagelatou, and D P Norgate, and R J Clarke, and J W Antoniw, and B A Stedman, and A Brennan, and R Welsby, and I Bujalska, and P M Stewart, and B A Cooke
September 2007, The Journal of endocrinology,
A E Michael, and M Evagelatou, and D P Norgate, and R J Clarke, and J W Antoniw, and B A Stedman, and A Brennan, and R Welsby, and I Bujalska, and P M Stewart, and B A Cooke
January 2001, Hypertension research : official journal of the Japanese Society of Hypertension,
A E Michael, and M Evagelatou, and D P Norgate, and R J Clarke, and J W Antoniw, and B A Stedman, and A Brennan, and R Welsby, and I Bujalska, and P M Stewart, and B A Cooke
February 1998, Molecular human reproduction,
A E Michael, and M Evagelatou, and D P Norgate, and R J Clarke, and J W Antoniw, and B A Stedman, and A Brennan, and R Welsby, and I Bujalska, and P M Stewart, and B A Cooke
September 1999, The American journal of physiology,
A E Michael, and M Evagelatou, and D P Norgate, and R J Clarke, and J W Antoniw, and B A Stedman, and A Brennan, and R Welsby, and I Bujalska, and P M Stewart, and B A Cooke
June 1997, The Journal of clinical endocrinology and metabolism,
Copied contents to your clipboard!